• Cell Counting Kit-8 (CCK-8): Precision Cell Proliferation As

  2026-07-01

  The Cell Counting Kit-8 (CCK-8) streamlines sensitive cell proliferation and viability assays, outperforming traditional tetrazolium-based workflows. Explore how CCK-8 empowers dynamic tissue engineering, advanced 4D bioprinting, and robust cytotoxicity screening with reproducible, quantitative results.

• Halazone: Antimicrobial Sulfonamide Derivative in Water & Ne

  2026-06-30

  Halazone stands apart as a dual-action antimicrobial sulfonamide derivative, enabling rapid, validated workflows in both water disinfection and neurophysiological research. Discover actionable protocols, troubleshooting insights, and comparative advantages that empower your lab to maximize reproducibility with this robust agent from APExBIO.

• Canagliflozin: SGLT2 Inhibitor Workflows for Diabetes Models

  2026-06-30

  Canagliflozin stands out as a selective SGLT2 inhibitor, enabling researchers to probe both glucose metabolism and mitochondrial remodeling in diabetes and kidney disease models. This guide details practical workflows, troubleshooting strategies, and protocol enhancements grounded in recent mechanistic discoveries.

• Nanoparticle-Enhanced Scaffolds Target Macrophages for Bone

  2026-06-29

  This study introduces a magneto-piezoelectric nanoparticle-loaded scaffold that disrupts biofilms and reprograms Icam1+ macrophages to improve infectious bone defect healing. By activating oxidative phosphorylation through JAK2-STAT3 signaling, the approach offers a dual anti-infective and pro-reparative strategy with significant translational potential.

• Palbociclib (PD0332991) Isethionate: Decoding CDK4/6 Inhibit

  2026-06-29

  Explore the molecular and experimental foundations of Palbociclib (PD0332991) Isethionate, a selective CDK4/6 inhibitor. This article uniquely bridges mechanistic insights with practical assay design and resistance modeling, offering actionable context for advanced breast and renal cancer research.

• V5 Epitope Tag Peptide: Precision Protein Tagging & Detectio

  2026-06-28

  The V5 Epitope Tag Peptide empowers accurate, multiplexed protein detection and purification—even in demanding single-molecule and super-resolution workflows. This article demystifies practical assay integration, protocol optimization, and troubleshooting, leveraging the latest antibody screening innovations and APExBIO’s high-purity platform.

• GSK J4 HCl: Strategic JMJD3 Inhibition for Translational Epi

  2026-06-27

  Explore how GSK J4 HCl, a potent JMJD3 inhibitor from APExBIO, is reshaping epigenetic regulation research by bridging mechanistic insight with actionable strategies. Featuring practical guidance, experimental validation, and a visionary outlook, this article uniquely synthesizes advances in histone demethylation, immune modulation, and translational relevance beyond standard product literature.

• Dynamic Covalent Lipid Nanoparticles Enable CRISPR Editing f

  2026-06-26

  Cao et al. introduce dynamically covalent lipid nanoparticles (LNPs) that deliver CRISPR-Cas9 components to retinal cells, achieving effective genome editing of VEGFA and reduction of choroidal neovascularization (CNV) in mice. This platform demonstrates a nonviral, biosafe approach with improved transfection and therapeutic performance, offering key insights for ocular gene therapy.

• Mitochondrial Calcium Signaling Suppresses Ferroptosis in Tu

  2026-06-26

  This study reveals that mitochondrial calcium uptake via MCU maintains GPX4 acetylation and activity, directly suppressing ferroptotic cell death in tumor models. The mechanistic findings connect mitochondrial metabolism and calcium signaling to ferroptosis resistance, with significant implications for cancer therapy research.

• METTL17 Regulates Ferroptosis via Mitochondrial Translation

  2026-06-25

  This study identifies METTL17 as a pivotal regulator of ferroptosis resistance and tumorigenesis in colorectal cancer by modulating mitochondrial RNA methylation and translation. The findings highlight METTL17 as a potential therapeutic target for sensitizing cancer cells to ferroptosis, informing future strategies for non-small-cell lung carcinoma and HER2-amplified breast cancer research.

• BX795: Selective PDK1 Inhibitor for Kinase and Immune Studie

  2026-06-25

  BX795 is a potent, ATP-competitive PDK1 inhibitor that also targets TBK1 and IKKε, enabling precise modulation of cancer cell growth and innate immune signaling. Its selectivity and well-characterized pharmacology make it a gold-standard tool for dissecting PI3K/Akt/mTOR pathways and antiviral immune responses.

• Anti-diabetic Agents and Weight Loss in Type 2 Diabetes: Rev

  2026-06-24

  This review systematically analyzes the weight-loss effects of non-insulin anti-diabetic drugs in patients with type 2 diabetes (T2D), highlighting a stratification of pharmacological agents by weight loss efficacy. Notably, Ertugliflozin (PF-04971729) is identified as inducing moderate weight loss, making it a meaningful option for addressing diabesity.

• Applied Use of Cell Counting Kit-8 (CCK-8) in Viability Assa

  2026-06-23

  Leverage the Cell Counting Kit-8 (CCK-8) from APExBIO for rapid, sensitive, and reproducible cell viability and cytotoxicity measurements. This article unpacks experimental workflows, advanced use-cases, and troubleshooting strategies that streamline cell proliferation and cytotoxicity studies, with practical insights from cutting-edge ferroptosis research.

• Tubastatin A: Selective HDAC6 Inhibitor for Translational Re

  2026-06-23

  Tubastatin A is a potent, highly selective HDAC6 inhibitor that enables targeted study of epigenetic regulation, cancer biology, inflammation, and neuroprotection. Its nanomolar efficacy and selectivity are validated in cardiac, oncological, and neural models. Recent studies confirm its role in reducing post-resuscitation myocardial damage via inhibition of pyroptosis and necroptosis.

• Cy5-UTP: Precision Fluorescent RNA Labeling for In Vitro App

  2026-06-22

  Cy5-UTP (Cyanine 5-uridine triphosphate) enables high-sensitivity, direct fluorescent RNA probe synthesis for in vitro transcription applications. Its stable Cy5 label allows accurate visualization in workflows like FISH and dual-color arrays, with robust incorporation and spectral properties supporting multiplexed detection.

454 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page